Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - Oncology, 2013 - karger.com
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - Oncology, 2013 - karger.com
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - Oncology, 2013 - cir.nii.ac.jp
抄録< jats: p> Background: Cetuximab and docetaxel have single-agent activity in
squamous cell carcinoma of the head and neck (SCCHN). The efficacy of their combination …
squamous cell carcinoma of the head and neck (SCCHN). The efficacy of their combination …
[PDF][PDF] M. Knoedler TC Gauler b V. Gruenwald c A. Matzdorff d M. Schroeder e A. Dietz f W.-O. Jordan g D. Arnold h B. Hennemann i C. Hofele j F. Weissinger k
W Eberhardt, U Keilholz - Oncology, 2013 - scholar.archive.org
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after …
M Knoedler, TC Gauler, V Gruenwald… - …, 2013 - epub.uni-regensburg.de
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum …
M Knoedler, TC Gauler, V Gruenwald… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - …, 2013 - search.ebscohost.com
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - Oncology, 2013 - europepmc.org
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or
metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy …
metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy …
Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after …
M Knoedler, TC Gauler, V Gruenwald, A Matzdorff… - …, 2013 - search.proquest.com
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
[PDF][PDF] M. Knoedler TC Gauler b V. Gruenwald c A. Matzdorff d M. Schroeder e A. Dietz f W.-O. Jordan g D. Arnold h B. Hennemann i C. Hofele j F. Weissinger k
W Eberhardt, U Keilholz - Oncology, 2013 - core.ac.uk
Background: Cetuximab and docetaxel have single-agent activity in squamous cell
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …
carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated …